Cabergoline 0.25 mg/tab 10 pills |

About Cabergoline | HilmaBiocare

Cabergoline - Hilma Biocare

Cabergoline is a prescription dopaminergic agent derived from ergoline. It acts as a dopamine D2-receptor agonist and is used in clinical practice under medical supervision to reduce elevated prolactin levels by inhibiting prolactin secretion from the pituitary gland.

General Overview

Class: Dopamine agonist (ergoline derivative)
Structure: Cabergoline
Context of use: Prescription medical use under professional supervision for conditions associated with hyperprolactinemia

Potentially Observed Effects
(based on pharmacological action and clinical use)

Reduction of circulating prolactin levels
Normalization of prolactin-related endocrine effects in responsive individuals
Possible effects on libido and overall well-being in cases where prolactin levels are elevated
Indirect effects on fluid balance and hormonal regulation in some individuals

Safety Information

Cabergoline may be associated with side effects and clinically relevant risks. Reported adverse effects can include headache, dizziness, nausea, fatigue or sleepiness, gastrointestinal discomfort, and changes in mood. Less commonly, cardiovascular effects and blood pressure changes may occur, particularly with long-term use or higher doses. Individual responses vary, and appropriate medical supervision and monitoring are recommended when clinically indicated.

Disclaimer: This text is provided for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always comply with the laws of your country and use prescription medicines only under qualified medical supervision.